Brief: Bolt Biotherapeutics Announces Issuance Of US Patent Covering Dectin-2-Targeting Agonist Antibodies
12/09/2023 14:39
Sept 12 (Reuters) - Bolt Biotherapeutics Inc BOLT.O :
* BOLT BIOTHERAPEUTICS ANNOUNCES ISSUANCE OF U.S. PATENT
COVERING
DECTIN-2-TARGETING AGONIST ANTIBODIES, INCLUDING BDC-3042
* BOLT BIOTHERAPEUTICS INC - CLAIMS OF PATENT WILL BE VALID
THROUGH MAY 2041
Source text for Eikon: ID:nGNXbJnPxR
Further company coverage: BOLT.O
((reuters.briefs@thomsonreuters.com;))